Katsuhito Hashidzume
Presidente en HUMAN METABOLOME TECHNOLOGIES, INC. .
Fortuna: 28 778 $ al 31/05/2024
Perfil
Katsuhito Hashidzume currently works at Human Metabolome Technologies, Inc., as President & Representative Director from 2019, HMT Biomedical KK, as President & Representative Director from 2018, and Mediome KK, as Non-Executive Director from 2018.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2023 | 7 044 ( 0.12% ) | 28 778 $ | 31/05/2024 |
Cargos activos de Katsuhito Hashidzume
| Empresas | Cargo | Inicio |
|---|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Presidente | 21/09/2019 |
HMT Biomedical KK
 HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Presidente | 01/12/2018 |
| Mediome KK | Director/Miembro de la Junta | 01/12/2018 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
HMT Biomedical KK
HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Health Technology |
| Mediome KK |
- Bolsa de valores
- Insiders
- Katsuhito Hashidzume
